By Hebert Alberto Vargas MD, Pier Luigi Di Paolo MD (auth.), Oguz Akin (eds.)
This e-book presents a complete visible evaluate of pathologic affliction adaptations of the 5 major forms of gynecologic cancers: ovarian, endometrial, cervical, vaginal, and vulvar. by using cross-sectional imaging modalities, together with computed tomography, magnetic resonance imaging, ultrasound, and positron emission tomography, it depicts common anatomy in addition to universal gynecological tumors. for every kind of melanoma, facets similar to fundamental staging, recurrence styles, and findings from varied but complementary imaging modalities are explored. Atlas of Gynecologic Oncology Imaging offers a coherent viewpoint of the jobs of ordinary and state of the art imaging options in gynecologic oncology through a multidisciplinary method of melanoma care. that includes over six hundred photographs, this booklet is a necessary source for diagnostic radiologists, radiation oncologists, and gynecologists.
Read or Download Atlas of Gynecologic Oncology Imaging PDF
Best oncology books
This textbook is a transparent and obtainable advent to the clinical and scientific features of the production, improvement and management of substances or drug regimens utilized in the therapy of melanoma. special in its process, this e-book allows the coed to realize an figuring out of the pathological, physiological and molecular techniques governing malignancy, while additionally introducing the function of health and wellbeing pros and scientists within the learn and therapy of melanoma.
As cells mature they certainly cease dividing and input a interval known as senescence. yet mobile senescence is additionally caused in advance via sure oncogenes considering melanoma improvement. mobile senescence, a growth-arrest application that limits the lifespan of mammalian cells and forestalls limitless mobile proliferation, is attracting enormous curiosity due to its hyperlinks to tumor suppression.
Fluorescence is the most important instrument for paintings on the frontier of telephone biology, photobiology and bioinstrumentation. The said goal of the workshop was once to focus on the importance of fluorescence paintings for the certainty of cellphone and tissue body structure, physiopathology and pharmacology, particulary when it comes to the analytical use of fluorescent probes in oncology.
Why do pink placebos stimulate while blue placebos calm? Why do extra placebos paintings greater than few? And why do dearer placebos paintings greater than more cost-effective ones? those are a few of the key questions that frequently are evoked after we ponder the slippery and counterintuitive box of placebo technology.
- Small Molecules in Oncology
- Cancer Gene Therapy
- Complementary Oncology: Adjunctive Methods in the Treatment of Cancer
- Principles and Practice of Palliative Care and Supportive Oncology
- Brain Metastases from Primary Tumors. Epidemiology, Biology, and Therapy
- Imaging in Oncology
Extra resources for Atlas of Gynecologic Oncology Imaging
Uk O. org O. A. Vargas et al. , depth of myometrial invasion) and evaluation of recurrence Evaluation of metastatic disease Positron emission tomography (PET) Advantages Readily available Cost-effective Usually well tolerated Fast Reproducible More widely available than MRI Superb contrast resolution No ionizing radiation Depicts both anatomy and function Whole-body evaluation Disadvantages Operator-dependent Limited accuracy in staging endometrial cancer Involves ionizing radiation Contrast resolution is not as good as ultrasound or MRI More expensive and less readily available than ultrasound or CT Radiation from both CT and PET component of the examination 2 Endometrial Cancer a 35 b c Fig.
Posttreatment Assessment and Recurrence The mainstay of ovarian cancer response assessment is based on serial measurements of serum CA 125 in combination with morphologic evaluation using CT, MRI, or both [18, 19]. The limitations of CA 125 as a tumor marker are well known. Normal values do not exclude the presence of disease, and elevated values usually indicate recurrence but cannot establish its location or extent [20– 22]. Imaging is comparable to laparotomy but superior to serum CA 125 in the detection of residual or recurrent peritoneal and serosal implants in women who have been treated for ovarian cancer [16, 23].
19. 20. 21. 22. 23. ovarian carcinoma: effect on survival. Radiology. 2011;258: 776–84. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities–report from the Radiological Diagnostic Oncology Group. Radiology. 2000;215:761–7. Coakley FV. Staging ovarian cancer: role of imaging. Radiol Clin North Am. 2002;40:609–36. 1007/s00330-010-1886-4. Forstner R, Sala E, Kinkel K, Spencer JA. ESUR guidelines: ovarian cancer staging and follow-up.